InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager

InDex Pharmaceuticals Holding AB

STO:FLERIE

Watchlist

Dividends

Discount Rate

Price: 45 SEK 0.78% Market Closed

Market Cap: 3.5B SEK

Have any thoughts about
InDex Pharmaceuticals Holding AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 45 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

FLERIE Alert

InDex Pharmaceuticals Holding AB

+0.35 (+0.78%)

52 Week Range	8.8 75.4
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

InDex Pharmaceuticals Holding AB

What unique competitive advantages
does InDex Pharmaceuticals Holding AB hold over its rivals?

What risks and challenges
does InDex Pharmaceuticals Holding AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of InDex Pharmaceuticals Holding AB.

What unique competitive advantages
does InDex Pharmaceuticals Holding AB hold over its rivals?

What risks and challenges
does InDex Pharmaceuticals Holding AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InDex Pharmaceuticals Holding AB.

Provide P/S
for InDex Pharmaceuticals Holding AB.

Provide P/E
for InDex Pharmaceuticals Holding AB.

Provide P/OCF
for InDex Pharmaceuticals Holding AB.

Provide P/FCFE
for InDex Pharmaceuticals Holding AB.

Provide P/B
for InDex Pharmaceuticals Holding AB.

Provide EV/S
for InDex Pharmaceuticals Holding AB.

Provide EV/GP
for InDex Pharmaceuticals Holding AB.

Provide EV/EBITDA
for InDex Pharmaceuticals Holding AB.

Provide EV/EBIT
for InDex Pharmaceuticals Holding AB.

Provide EV/OCF
for InDex Pharmaceuticals Holding AB.

Provide EV/FCFF
for InDex Pharmaceuticals Holding AB.

Provide EV/IC
for InDex Pharmaceuticals Holding AB.

Show me price targets
for InDex Pharmaceuticals Holding AB made by professional analysts.

What are the Revenue projections
for InDex Pharmaceuticals Holding AB?

How accurate were the past Revenue estimates
for InDex Pharmaceuticals Holding AB?

What are the Net Income projections
for InDex Pharmaceuticals Holding AB?

How accurate were the past Net Income estimates
for InDex Pharmaceuticals Holding AB?

What are the EPS projections
for InDex Pharmaceuticals Holding AB?

How accurate were the past EPS estimates
for InDex Pharmaceuticals Holding AB?

What are the EBIT projections
for InDex Pharmaceuticals Holding AB?

How accurate were the past EBIT estimates
for InDex Pharmaceuticals Holding AB?

Compare the revenue forecasts
for InDex Pharmaceuticals Holding AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InDex Pharmaceuticals Holding AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InDex Pharmaceuticals Holding AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of InDex Pharmaceuticals Holding AB compared to its peers.

Compare the P/E ratios
of InDex Pharmaceuticals Holding AB against its peers.

Discuss the investment returns and shareholder value creation
comparing InDex Pharmaceuticals Holding AB with its peers.

Analyze the financial leverage
of InDex Pharmaceuticals Holding AB compared to its main competitors.

Show all profitability ratios
for InDex Pharmaceuticals Holding AB.

Provide ROE
for InDex Pharmaceuticals Holding AB.

Provide ROA
for InDex Pharmaceuticals Holding AB.

Provide ROIC
for InDex Pharmaceuticals Holding AB.

Provide ROCE
for InDex Pharmaceuticals Holding AB.

Provide Gross Margin
for InDex Pharmaceuticals Holding AB.

Provide Operating Margin
for InDex Pharmaceuticals Holding AB.

Provide Net Margin
for InDex Pharmaceuticals Holding AB.

Provide FCF Margin
for InDex Pharmaceuticals Holding AB.

Show all solvency ratios
for InDex Pharmaceuticals Holding AB.

Provide D/E Ratio
for InDex Pharmaceuticals Holding AB.

Provide D/A Ratio
for InDex Pharmaceuticals Holding AB.

Provide Interest Coverage Ratio
for InDex Pharmaceuticals Holding AB.

Provide Altman Z-Score Ratio
for InDex Pharmaceuticals Holding AB.

Provide Quick Ratio
for InDex Pharmaceuticals Holding AB.

Provide Current Ratio
for InDex Pharmaceuticals Holding AB.

Provide Cash Ratio
for InDex Pharmaceuticals Holding AB.

What is the historical Revenue growth
over the last 5 years for InDex Pharmaceuticals Holding AB?

What is the historical Net Income growth
over the last 5 years for InDex Pharmaceuticals Holding AB?

What is the current Free Cash Flow
of InDex Pharmaceuticals Holding AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for InDex Pharmaceuticals Holding AB.

EV/EBIT
Enterprise Value to EBIT

-11

Current

-70.7

Median

16.8

Industry

Higher than median

Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT

-11

Enterprise Value

2.6B SEK

EBIT

-238.9m SEK

All Countries

Forward Multiples

			Market Cap	EV/EBIT
SE	I	InDex Pharmaceuticals Holding AB STO:FLERIE	3.5B SEK	-11
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 046 864.6
US		Eli Lilly and Co NYSE:LLY	788.1B USD	56.4
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	17 702.3
DK		Novo Nordisk A/S CSE:NOVO B	3.4T DKK	28.7
US		Johnson & Johnson NYSE:JNJ	384.8B USD	16.5
US		Merck & Co Inc NYSE:MRK	259.4B USD	15.8
CH		Roche Holding AG SIX:ROG	213.6B CHF	12.4
UK		AstraZeneca PLC LSE:AZN	171.2B GBP	255.6
CH		Novartis AG SIX:NOVN	183.5B CHF	15.4
US		Pfizer Inc NYSE:PFE	160.4B USD	16.7

				EBIT Growth
SE	I	InDex Pharmaceuticals Holding AB STO:FLERIE	Average EV/EBIT: 2 013.3 Negative Multiple: -11	N/A
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 046 864.6	N/A
US		Eli Lilly and Co NYSE:LLY	56.4	212%
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	675%
DK		Novo Nordisk A/S CSE:NOVO B	28.7	85%
US		Johnson & Johnson NYSE:JNJ	16.5	29%
US		Merck & Co Inc NYSE:MRK	15.8	695%
CH		Roche Holding AG SIX:ROG	12.4	27%
UK		AstraZeneca PLC LSE:AZN	255.6	131%
CH		Novartis AG SIX:NOVN	15.4	54%
US		Pfizer Inc NYSE:PFE	16.7	63%

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBIT

-10.3

2-Years Forward

EV/EBIT

-11.8

3-Years Forward

EV/EBIT

N/A

InDex Pharmaceuticals Holding AB
STO:FLERIE

EV/EBIT
Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

InDex Pharmaceuticals Holding AB STO:FLERIE

EV/EBIT Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

InDex Pharmaceuticals Holding AB
STO:FLERIE

EV/EBIT
Enterprise Value to EBIT